https://www.selleckchem.com/pr....oducts/3-amino-9-eth
Generally, progression-free survival was 69.8%±2.4%. The level of interleukin (IL)-6 and IL-10 and the combination of younger age and lower pathologic grade at diagnosis were independent prognostic factors by Cox regression analysis (P=.009 and .018, respectively). Children with lower levels of IL-6 and IL-10, or with younger age and lower pathologic grades, generally had favorable outcomes at the terminal point of follow-up, indicating better prognostic signs. Children with lower levels of IL-6 and IL-10, or with young
Like
Comment
Share
